Showing results (41-50 of 270) with videos related to
Sort By:
Pageof 27
Neuropharmacology|June 1, 1991
Tolerance to the behavioural effect of serotonergic (5-HT1B) agonists in the isolation-induced social behavioural deficit testH Frances, C MonierPharmacology, Biochemistry, and Behavior|October 1, 1991
Isolation increases a behavioral response to the selective 5-HT 1B agonist CGS 120 66BH Frances, C MonierNeuropsychobiology|January 1, 1983
Placebo use in clinical trials on psychotropic drugs in FranceJ D Guelfi, P Boyer, J F DreyfusBritish Journal of Clinical Pharmacology|January 1, 1983
A double-blind controlled clinical trial comparing fluvoxamine with imipramineJ D Guelfi, J F Dreyfus, P PichotPsychopharmacology Bulletin|October 15, 2016
Assessment of Anxiety in Clinical Trials with Depressed Patients Using the Hamilton Depression Rating ScaleC Goldberger, J D Guelfi, D V SheehanProgress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1992
Behavioral tolerance to one effect of the serotonergic agonist TFMPPH Frances, C MonierNeuropsychobiology|January 1, 1989
Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptylineJ D Guelfi, P Pichot, J F DreyfusEuropean Psychiatry : the Journal of the Association of European Psychiatrists|February 23, 2000
Psychometric qualities of the French version of the Heinrichs quality of life rating scaleS Simon-Abbadi, J D Guelfi, D GinestetL'Encephale|December 16, 1998
[alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo]E G Hantouche, J D Guelfi, D CometAnnales Medico-Psychologiques|June 1, 1984
[Factor structure of the H.S.C.L. in a sample of French anxious-depressed patients]J D Guelfi, G Barthelet, S Lancrenon, et al.Pageof 27